We are live on ! Find out more
ABUS icon

Arbutus Biopharma
ABUS

122 hedge funds and large institutions have $154M invested in Arbutus Biopharma in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 19

73% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 22

52% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $9.51M

23% more funds holding

Funds holding: 99 → 122 (+23)

3% more capital invested

Capital invested by funds: $149M → $154M (+$4.95M)

5.95% less ownership

Funds ownership: 35.18% → 29.24% (-5.9%)

Holders
122
Holders Change
+23
Holders Change %
+23.23%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
43
Increased
38
Reduced
22
Closed
19
Calls
$14.4M
Puts
$9.51M
Net Calls
+$4.92M
Net Calls Change
-$893K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$7.84M
2
BC
Brookfield Corp
Ontario, Canada
+$4.63M
3
N
Nuveen
North Carolina
+$3.47M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.07M
5
GPP
Great Point Partners
Connecticut
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$8.66M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.84M
3
SG Americas Securities
SG Americas Securities
New York
-$2.24M
4
WP
Woodline Partners
California
-$2.13M
5
Marshall Wace
Marshall Wace
United Kingdom
-$1.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
PGAM
101
Princeton Global Asset Management
New Jersey
$8K – – –
PMFA
102
Plante Moran Financial Advisors
Michigan
$8K +$7.77K +2,000 New
National Bank of Canada
103
National Bank of Canada
Quebec, Canada
$7K +$7.07K +1,820 New
BBPWM
104
Blue Bell Private Wealth Management
Pennsylvania
$6K +$5.83K +1,500 New
GWS
105
Glassman Wealth Services
Virginia
$5K +$4.81K +1,238 New
TWC
106
TD Waterhouse Canada
Ontario, Canada
$3.35K +$3.5K +900 New
FDCDDQ
107
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.11K – – –
GWM
108
Geneos Wealth Management
Colorado
$3K – – –
HIA
109
Harbor Investment Advisory
Maryland
$2K – – –
PA
110
Parallel Advisors
California
$2K – – –
Daiwa Securities Group
111
Daiwa Securities Group
Japan
$2K +$913 +235 +147%
US Bancorp
112
US Bancorp
Minnesota
$2K +$1.84K +475 New
MTWM
113
Masso Torrence Wealth Management
New Jersey
$2K +$1.94K +500 New
Koshinski Asset Management
114
Koshinski Asset Management
Illinois
$1.95K – – –
TF
115
TimeScale Financial
Massachusetts
$1K – – –
TWA
116
TCI Wealth Advisors
Arizona
$1K +$777 +200 New
Manulife (Manufacturers Life Insurance)
117
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$167 -$12.5K -3,219 -7%
Point72 Asset Management
118
Point72 Asset Management
Connecticut
– -$3.84M -895,200 Closed
WP
119
Woodline Partners
California
– -$2.13M -496,172 Closed
Marshall Wace
120
Marshall Wace
United Kingdom
– -$1.7M -397,088 Closed
CAC
121
Cowen and Company
New York
– -$1.07M -249,215 Closed
KA
122
Kerrisdale Advisers
Florida
– -$429K -100,000 Closed
PVI
123
Pura Vida Investments
New York
– -$429K -100,000 Closed
ACA
124
Apis Capital Advisors
New York
– -$300K -70,000 Closed
SC
125
Shay Capital
New York
– -$257K -60,000 Closed
2 3 4
5
6

ABUS Hedge Fund Activity: Q4 2021 in Review

122 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Arbutus Biopharma (ABUS) for Q4 2021, worth a combined $154M — up 3.3% from $149M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ABUS positions and 19 closed out — a net gain of 24 holders — while 38 added to existing stakes and 22 trimmed.

The largest buyer was Millennium Management, adding an estimated $7.84M. The largest seller was RTW Investments, cutting an estimated $8.66M.

  • 122 institutional investors held Arbutus Biopharma (ABUS) as of Q4 2021, up from 99 in Q3 2021.
  • Funds reported $154M of Arbutus Biopharma stock for Q4 2021, up 3.3% quarter-over-quarter.
  • 43 funds opened new Arbutus Biopharma positions in Q4 2021 and 19 closed out, a net change of +24 holders.
  • The largest Arbutus Biopharma buyer in Q4 2021 was Millennium Management, an estimated $7.84M added.
  • The largest Arbutus Biopharma seller in Q4 2021 was RTW Investments, an estimated $8.66M sold.

Based on aggregated 13F filings for Q4 2021.